Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fears

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 10, 2021
Exhaled aerosol increases with COVID-19 infection, age, and obesityDavid A Edwards, Dennis Ausiello, Jonathan Salzman, et al.
The Journal of Clinical Investigation|November 29, 2022
Recombinant vesicular stomatitis virus-vectored vaccine induces long-lasting immunity against Nipah virus diseaseCourtney Woolsey, Viktoriya Borisevich, Alyssa C Fears, et al.
Communications Biology|December 16, 2022
The dynamics of γδ T cell responses in nonhuman primates during SARS-CoV-2 infectionAlyssa C Fears, Edith M Walker, Nicole Chirichella, et al.
Emerging Microbes & Infections|January 2, 2024
Monoclonal antibody therapy demonstrates increased virulence of a lineage VII strain of Lassa virus in nonhuman primatesCourtney Woolsey, Robert W Cross, Abhishek N Prasad, et al.
Brain and Behavior|February 28, 2018
Neurodegenerative disease biomarkers Aβ<sub>1-40</sub>, Aβ<sub>1-42</sub>, tau, and p-tau<sub>181</sub> in the vervet monkey cerebrospinal fluid: Relation to normal aging, genetic influences, and cerebral amyloid angiopathyJason A Chen, Scott C Fears, Anna J Jasinska, et al.
Cell Reports. Medicine|January 27, 2024
Monoclonal antibody therapy protects nonhuman primates against mucosal exposure to Lassa virusRobert W Cross, Karla A Fenton, Courtney Woolsey, et al.
Frontiers in Cellular and Infection Microbiology|December 6, 2021
Effective Prophylaxis of COVID-19 in Rhesus Macaques Using a Combination of Two Parenterally-Administered SARS-CoV-2 Neutralizing AntibodiesBrandon J Beddingfield, Nicholas J Maness, Alyssa C Fears, et al.
Emerging Microbes & Infections|August 6, 2025
Experimental challenge of African green monkeys with contemporary Hendra virus isolates produces divergent clinical diseaseDeclan D Pigeaud, Karla A Fenton, Jacquelyn Turcinovic, et al.
Emerging Infectious Diseases|June 23, 2020
Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol SuspensionsAlyssa C Fears, William B Klimstra, Paul Duprex, et al.
Plos Pathogens|July 5, 2022
Exposure modality influences viral kinetics but not respiratory outcome of COVID-19 in multiple nonhuman primate speciesAlyssa C Fears, Brandon J Beddingfield, Nicole R Chirichella, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|February 10, 2021
Exhaled aerosol increases with COVID-19 infection, age, and obesityDavid A Edwards, Dennis Ausiello, Jonathan Salzman, et al.
The Journal of Clinical Investigation|November 29, 2022
Recombinant vesicular stomatitis virus-vectored vaccine induces long-lasting immunity against Nipah virus diseaseCourtney Woolsey, Viktoriya Borisevich, Alyssa C Fears, et al.
Communications Biology|December 16, 2022
The dynamics of γδ T cell responses in nonhuman primates during SARS-CoV-2 infectionAlyssa C Fears, Edith M Walker, Nicole Chirichella, et al.
Emerging Microbes & Infections|January 2, 2024
Monoclonal antibody therapy demonstrates increased virulence of a lineage VII strain of Lassa virus in nonhuman primatesCourtney Woolsey, Robert W Cross, Abhishek N Prasad, et al.
Brain and Behavior|February 28, 2018
Neurodegenerative disease biomarkers Aβ<sub>1-40</sub>, Aβ<sub>1-42</sub>, tau, and p-tau<sub>181</sub> in the vervet monkey cerebrospinal fluid: Relation to normal aging, genetic influences, and cerebral amyloid angiopathyJason A Chen, Scott C Fears, Anna J Jasinska, et al.
Cell Reports. Medicine|January 27, 2024
Monoclonal antibody therapy protects nonhuman primates against mucosal exposure to Lassa virusRobert W Cross, Karla A Fenton, Courtney Woolsey, et al.
Frontiers in Cellular and Infection Microbiology|December 6, 2021
Effective Prophylaxis of COVID-19 in Rhesus Macaques Using a Combination of Two Parenterally-Administered SARS-CoV-2 Neutralizing AntibodiesBrandon J Beddingfield, Nicholas J Maness, Alyssa C Fears, et al.
Emerging Microbes & Infections|August 6, 2025
Experimental challenge of African green monkeys with contemporary Hendra virus isolates produces divergent clinical diseaseDeclan D Pigeaud, Karla A Fenton, Jacquelyn Turcinovic, et al.
Emerging Infectious Diseases|June 23, 2020
Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol SuspensionsAlyssa C Fears, William B Klimstra, Paul Duprex, et al.
Plos Pathogens|July 5, 2022
Exposure modality influences viral kinetics but not respiratory outcome of COVID-19 in multiple nonhuman primate speciesAlyssa C Fears, Brandon J Beddingfield, Nicole R Chirichella, et al.
Pageof 4